Search

Your search keyword '"Macansh, Sacha"' showing total 5 results
Start Over Author "Macansh, Sacha" Publisher european respiratory society
5 results on '"Macansh, Sacha"'

1. Late Breaking Abstract - A composite serum biomarker index for the diagnosis of systemic sclerosis associated interstitial lung disease: a multicentre, observational, cohort study

Author

Jee, Adelle S., primary, Stewart, Iain, additional, Youssef, Peter, additional, Adelstein, Stephen, additional, Lai, Donna, additional, Hua, Sheng, additional, Stevens, Wendy Mr, additional, Proudman, Susanna, additional, Ngian, Gene-Siew, additional, Glaspole, Ian N, additional, Moodley, Yuben P, additional, Bleasel, Jane F, additional, Macansh, Sacha, additional, Nikpour, Mandana, additional, Sahhar, Joanne, additional, Corte, Tamera J, additional, and On Behalf Of The Australian Scleroderma Cohor, ., additional

Published
2021
Full Text
View/download PDF

2. Disease progression at 12 months does not predict future outcomes in IPF patients: Analysis from the Australian IPF Registry

Author

Jo, Helen, primary, Glaspole, Ian, additional, Grainge, Christopher, additional, Goh, Nicole, additional, Hopkins, Peter, additional, Moodley, Yuben, additional, Reynolds, Paul, additional, Chapman, Sally, additional, Walters, Haydn, additional, Zappala, Christopher, additional, Allan, Heather, additional, Keir, Gregory, additional, Hayen, Andrew, additional, Cooper, Wendy, additional, Mahar, Annabelle, additional, Ellis, Samantha, additional, Macansh, Sacha, additional, and Corte, Tamera, additional

Published
2017
Full Text
View/download PDF

3. Quality of life of patients with idiopathic pulmonary fibrosis (IPF) - What can the Australian IPF registry tell us?

Author

Glaspole, Ian, primary, Goh, Nicole, additional, Hopkins, Peter, additional, Moodley, Yuben, additional, Reynolds, P.N., additional, Walters, E.H, additional, Zappala, Christopher, additional, Allan, Heather, additional, Chapman, Sally, additional, Cooper, Wendy, additional, Ellis, Samantha, additional, Mahar, Annabelle, additional, Chaplin, Heather, additional, Henson, Robert, additional, Macansh, Sacha, additional, Richards, Sarah, additional, Smith, Susan E., additional, Symons, Karen, additional, Paul, Eldho, additional, and Corte, Tamera, additional

Published
2015
Full Text
View/download PDF

4. Determinants and outcomes of prolonged anxiety and depression in idiopathic pulmonary fibrosis.

Author

Glaspole IN, Watson AL, Allan H, Chapman S, Cooper WA, Corte TJ, Ellis S, Grainge C, Goh N, Hopkins P, Keir G, Macansh S, Mahar A, Moodley Y, Reynolds PN, Ryerson CJ, Walters EH, Zappala CJ, and Holland AE

Subjects
Aged, Australia epidemiology, Female, Humans, Logistic Models, Male, Middle Aged, Multivariate Analysis, Quality of Life, Registries, Visual Analog Scale, Anxiety epidemiology, Depression epidemiology, Idiopathic Pulmonary Fibrosis psychology
Abstract

Competing Interests: Conflict of interest: Disclosures can be found alongside this article at erj.ersjournals.com

Published
2017
Full Text
View/download PDF

5. Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian Idiopathic Pulmonary Fibrosis Registry.

Author

Jo HE, Glaspole I, Grainge C, Goh N, Hopkins PM, Moodley Y, Reynolds PN, Chapman S, Walters EH, Zappala C, Allan H, Keir GJ, Hayen A, Cooper WA, Mahar AM, Ellis S, Macansh S, and Corte TJ

Subjects
Adult, Age Distribution, Aged, Aged, 80 and over, Australia epidemiology, Carbon Monoxide blood, Female, Follow-Up Studies, Humans, Idiopathic Pulmonary Fibrosis drug therapy, Male, Middle Aged, Multivariate Analysis, Prospective Studies, Registries, Survival Analysis, Vital Capacity, Idiopathic Pulmonary Fibrosis mortality, Idiopathic Pulmonary Fibrosis physiopathology, Lung physiopathology
Abstract

7The prevalence of idiopathic pulmonary fibrosis (IPF), a fatal and progressive lung disease, is estimated at 1.25-63 out of 100 000, making large population studies difficult. Recently, the need for large longitudinal registries to study IPF has been recognised.The Australian IPF Registry (AIPFR) is a national registry collating comprehensive longitudinal data of IPF patients across Australia. We explored the characteristics of this IPF cohort and the effect of demographic and physiological parameters and specific management on mortality.Participants in the AIPFR (n=647, mean age 70.9±8.5 years, 67.7% male, median follow up 2 years, range 6 months-4.5 years) displayed a wide range of age, disease severity and co-morbidities that is not present in clinical trial cohorts. The cumulative mortality rate in year one, two, three and four was 5%, 24%, 37% and 44% respectively. Baseline lung function (forced vital capacity, diffusing capacity of the lung for carbon monoxide, composite physiological index) and GAP (gender, age, physiology) stage (hazard ratio 4.64, 95% CI 3.33-6.47, p<0.001) were strong predictors of mortality. Patients receiving anti-fibrotic medications had better survival (hazard ratio 0.56, 95% CI 0.34-0.92, p=0.022) than those not on anti-fibrotic medications, independent of underlying disease severity.The AIPFR provides important insights into the understanding of the natural history and clinical management of IPF., (Copyright ©ERS 2017.)

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results